Voy­ager taps new busi­ness chief amid 'sig­nif­i­cant in­ter­est' from part­ners; On­copep­tides faces an­oth­er CEO, CFO re­set

Beth Shafer was taught to leave a place bet­ter than she found it. As Voy­ager Ther­a­peu­tics’ new chief busi­ness of­fi­cer, that’s ex­act­ly what she in­tends to do.

Voy­ager an­nounced Mon­day that it tapped the Take­da vet­er­an for its C-suite. Shafer will lead the busi­ness strat­e­gy as the com­pa­ny says its AAV cap­sid plat­form and neu­rol­o­gy pro­grams “con­tin­ue to at­tract sig­nif­i­cant in­ter­est from third par­ties.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER